Provided by Tiger Trade Technology Pte. Ltd.

Enveric Biosciences

1.49
+0.03002.05%
Post-market: 1.48-0.0110-0.74%17:16 EDT
Volume:51.65K
Turnover:76.62K
Market Cap:6.67M
PE:-0.20
High:1.54
Open:1.45
Low:1.45
Close:1.46
52wk High:13.25
52wk Low:1.17
Shares:4.48M
Float Shares:4.34M
Volume Ratio:0.99
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4858
EPS(LYR):-36.2437
ROE:-170.04%
ROA:-87.34%
PB:0.83
PE(LYR):-0.04

Loading ...

Enveric receives Notice of Allowance from USPTO for application for EVM401

TIPRANKS
·
Sep 15

Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in Evm401 Series

THOMSON REUTERS
·
Sep 15

Enveric Biosciences to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 01

Cancer Immunotherapy Developer CEL-SCI's Q3 Net Loss Unchanged

Reuters
·
Aug 17

Enveric Biosciences Q2 EPS $(0.76) Up From $(11.64) YoY

Benzinga Earnings
·
Aug 15

Enveric Net Loss Narrows to $3 Million in Q2 FY26; Loss Per Share Improves to $0.76

Reuters
·
Aug 15

Enveric Biosciences Q2 Net Income USD -3 Million

THOMSON REUTERS
·
Aug 15

Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026

Dow Jones
·
Aug 15

Enveric Biosciences Says Preclinical GloSensor Assay Supports Non-Hallucinogenic Profile for EB-003

Reuters
·
Aug 05

Enveric Welcomes Final FDA Guidance on Psychedelic Drug Trials

Reuters
·
Jul 28

Enveric Biosciences to Feature at B. Riley Securities Summit, Highlighting Neuroplastogen Development

Deep News
·
Jun 30

Enveric Biosciences CEO Joins B. Riley Securities Neuropsychiatry Fireside Chat at Mind, Muscle & Vision Summit

Reuters
·
Jun 29

Enveric Biosciences to attend BIO International Convention

Reuters
·
Jun 16

Enveric Biosciences Expands At-The-Market Equity Offering

TIPRANKS
·
Jun 10

Enveric Biosciences files prospectus supplement to offer additional $2.43 million in shares via ATM agreement

Reuters
·
Jun 10

Enveric Biosciences to attend UBS Virtual CNS Day

Reuters
·
Jun 09

Enveric Biosciences Begins Genotoxicity Testing for EB-003

MT Newswires Live
·
Jun 02

Enveric Biosciences starts IND-enabling genotoxicity studies for lead neuroplastogen EB-003

Reuters
·
Jun 02

Enveric Biosciences Initiates Investigational New Drug (Ind)-Enabling Genotoxicity Studies of Lead Neuroplastogen Candidate Eb-003

THOMSON REUTERS
·
Jun 02

Enveric Biosciences - Initiates Ind-Enabling Genotoxicity Studies for Eb-3

THOMSON REUTERS
·
Jun 02